0.9995
전일 마감가:
$1.07
열려 있는:
$1.06
하루 거래량:
1.66M
Relative Volume:
3.62
시가총액:
$104.42M
수익:
$241.52M
순이익/손실:
$-199.30M
주가수익비율:
-0.7967
EPS:
-1.2546
순현금흐름:
$37.06M
1주 성능:
-11.55%
1개월 성능:
-36.34%
6개월 성능:
-76.26%
1년 성능:
-64.56%
Definitive Healthcare Corp Stock (DH) Company Profile
명칭
Definitive Healthcare Corp
전화
508-720-4224
주소
492 OLD CONNECTICUT PATH, SUITE 401, FRAMINGHAM
Compare DH vs VEEV, TEM, BTSG, HQY, MMED
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
DH
Definitive Healthcare Corp
|
0.9995 | 111.79M | 241.52M | -199.30M | 37.06M | -1.2546 |
|
VEEV
Veeva Systems Inc
|
185.59 | 30.25B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
48.74 | 8.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
43.99 | 8.27B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
81.13 | 6.80B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
MMED
Minimed Group Inc
|
17.11 | 4.71B | 0 | 0 | 0 | 0.00 |
Definitive Healthcare Corp Stock (DH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-09 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-01-13 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2024-12-20 | 개시 | Stephens | Equal-Weight |
| 2024-09-17 | 개시 | BTIG Research | Buy |
| 2024-07-31 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2024-05-08 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-17 | 다운그레이드 | Needham | Buy → Hold |
| 2024-01-05 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-07-24 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2023-04-19 | 개시 | William Blair | Outperform |
| 2022-12-09 | 개시 | BofA Securities | Neutral |
| 2022-07-06 | 개시 | Needham | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Neutral |
| 2022-02-24 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-12-16 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-11-17 | 개시 | Robert W. Baird | Outperform |
| 2021-10-11 | 개시 | Barclays | Equal Weight |
| 2021-10-11 | 개시 | Canaccord Genuity | Hold |
| 2021-10-11 | 개시 | Credit Suisse | Neutral |
| 2021-10-11 | 개시 | Deutsche Bank | Hold |
| 2021-10-11 | 개시 | Goldman | Neutral |
| 2021-10-11 | 개시 | JP Morgan | Neutral |
| 2021-10-11 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-10-11 | 개시 | Raymond James | Mkt Perform |
| 2021-10-11 | 개시 | Stifel | Buy |
모두보기
Definitive Healthcare Corp 주식(DH)의 최신 뉴스
Definitive Healthcare Corp. (DH) matches Q4 earnings estimates - MSN
Definitive Healthcare (NASDAQ:DH) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Institution Moves: Is Definitive Healthcare Corp forming a double bottom2026 Selloffs & Entry Point Confirmation Signals - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH), Myomo (MYO) and OS Therapies Incorporated (OSTX) - The Globe and Mail
Definitive Healthcare stock holds at Neutral as revenue declines persist By Investing.com - Investing.com Canada
Definitive Healthcare stock holds at Neutral as revenue declines persist - Investing.com
Definitive Healthcare (NASDAQ:DH) Cut to Strong Sell at Zacks Research - Defense World
DH Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Definitive Healthcare Corp. Hits New 52-Week Low at $1.10 - Markets Mojo
Zacks Research Downgrades Definitive Healthcare (NASDAQ:DH) to Strong Sell - MarketBeat
Gap Down: Can Definitive Healthcare Corp outperform under higher oil pricesJuly 2025 Update & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1 - Sahm
Definitive Healthcare Stock Quote, Share Price, News and Analysis - Longbridge
Definitive Healthcare (DH) Earnings Transcript - AOL.com
Pullback Watch: Will Definitive Healthcare Corp benefit from current market trendsPortfolio Update Report & Weekly Watchlist of Top Performers - baoquankhu1.vn
Definitive Healthcare Corp. Hits New 52-Week Low at $1.14 - Markets Mojo
Tax-withholding share transfer by Definitive Healthcare (DH) CEO Coop - Stock Titan
Definitive Healthcare Earnings Call Balances Profit and Pressure - TipRanks
Canaccord Genuity Group Lowers Definitive Healthcare (NASDAQ:DH) Price Target to $3.00 - Defense World
DH PE Ratio & Valuation, Is DH Overvalued - Intellectia AI
Definitive Healthcare (NASDAQ:DH) Stock Rating Lowered by Wall Street Zen - Defense World
Definitive Healthcare Q4 2025 slides: profit gains amid revenue decline - Investing.com Australia
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Stephens cuts Definitive Healthcare stock price target on revenue decline - Investing.com Nigeria
Canaccord Genuity Group Has Lowered Expectations for Definitive Healthcare (NASDAQ:DH) Stock Price - MarketBeat
Definitive Healthcare earnings missed by $0.15, revenue topped estimates - Investing.com South Africa
Stephens Cuts Definitive Healthcare (NASDAQ:DH) Price Target to $2.00 - MarketBeat
Deutsche Bank Adjusts Definitive Healthcare PT to $3 From $6, Maintains Hold Rating - marketscreener.com
Definitive Healthcare Corp. (DH) Stock Analysis: Exploring a 152% Potential Upside Opportunity - DirectorsTalk Interviews
Definitive Healthcare Corp. Q4 2025 Earnings Call Summary - Yahoo Finance
Stephens cuts Definitive Healthcare stock price target on revenue decline By Investing.com - Investing.com India
Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Definitive Healthcare Corp (DH) Q4 2025 Earnings Call Highlights: Navigating Revenue Challenges ... By GuruFocus - Investing.com Canada
Definitive Healthcare Q4 Earnings Call Highlights - MarketBeat
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2025 - National Today
Definitive Healthcare (NASDAQ:DH) Posts Earnings Results - MarketBeat
Definitive Healthcare Q4 2025 slides: profit gains amid revenue decline By Investing.com - Investing.com South Africa
DH: Revenue and profitability beat guidance, retention improved, and claims data disruption was resolved - TradingView
Definitive Healthcare (NASDAQ:DH) Updates FY 2026 Earnings Guidance - MarketBeat
Definitive Healthcare (NASDAQ:DH) Releases Q1 2026 Earnings Guidance - MarketBeat
Earnings call transcript: Definitive Healthcare Q4 2025 reports revenue beat, EPS miss - Investing.com
Definitive Healthcare Corp. (DH) Matches Q4 Earnings Estimates - Yahoo Finance
DH: Q4 results beat expectations; 2026 outlook cautious but retention and innovation improving - TradingView
Definitive Healthcare Corp. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:DH) 2026-02-26 - Seeking Alpha
Definitive Healthcare Corp. (DH) stock falls on Q4 2025 Earnings - Quiver Quantitative
Definitive Healthcare (DH) CFO receives 733,301 RSU equity award in new grant - Stock Titan
Definitive Healthcare (DH) CEO granted 1.7M RSUs in new equity award - Stock Titan
Definitive Healthcare (NASDAQ: DH) chair awarded 242,719 RSUs vesting 2027 - Stock Titan
Definitive Healthcare (DH) EVP corrects Form 3, discloses 4,045.654 shares - Stock Titan
Definitive Healthcare Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
[8-K] Definitive Healthcare Corp. Reports Material Event | DH SEC FilingForm 8-K - Stock Titan
Definitive Healthcare Corp (DH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):